MK
Mark Kaye sold $4.7M of ELV stock
Mark Kaye, EVP & CFO of Elevance Health, Inc. (ELV), sold 10,584 shares of ELV stock worth $4.7M, per an SEC Form 4 filed Oct 23, 2026.
It was an open-market sale.
The trade happened on Oct 22, 2026, 1 day before it was made public.
ELV has moved -3.5% since the trade date, from $445.28 to $429.69 (Nov 13, 2026 close).
- Traded
- Oct 22, 2026
- Disclosed
- Oct 23, 2026
- Filing delay
- 1 day
- Price since
- -3.5%
- Role
- EVP & CFO
- Source
- SEC Form 4